Since we last met with Paolo Carli in 2013, he has been given greater responsibilities within Merck and is now Head of Middle East, Africa, Turkey, Russia, and CIS countries for the healthcare business. Paolo discusses the logic behind being assigned such a vast region to manage, Merck's strategy for both entering and thriving in new markets and the company’s offering for equitable provision of medicines across Africa, among other interesting topics.
We believe the UAE is uniquely positioned to ride the new evolution of the industry, and when it comes to pharma, research is an area where UAE could establish itself further.
